United States · Who invested in IngagePatient?
IngagePatient's investors include Harbert Venture Partners.
201320142015
$4.1MSeries A$750KDebt$2.4MVentureUnited States · Venture startup
Who invested in IngagePatient
Funding summaryUpdated 26 Oct 2026
$7.3Mraised across 3 rounds since 2012, from 3 sources
$4.1MSeries A$750KDebt$2.4MVenture
- Latest round
- Venture, $2.4MJul 2015
- Biggest round
- $4.1MSeries A · Oct 2012
- Step-upi
- 3.2×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $4.1M Oct 2012
- Biggest round
- $4.1M Series A · Oct 2012
- Usual gap between rounds
- 21 months the median of 2
The rounds
- Jul 2015Venture$2.4M
No investor was named in the report.
From a historical funding recordSEC filing: $2.4M sold, first sale Jul 2015
- Jul 2014Debt$750K
No investor was named in the report.
From a historical funding recordSEC filing: $750K sold, first sale Jun 2014
- Oct 2012
Founders and team
From the SEC filings it signed: 4 on the team.
- David WilliamsDirector, Promoteri
- Gregory BaileyPromoteri
- Joanne RohdeExecutive Officer, Directori
- Richard AllenDirector, Promoteri
On the board, as filediJohn TrbovichRobert Crutchfield
Quick answers about IngagePatient
How much has IngagePatient raised?
IngagePatient has raised $7.3M across 3 rounds since 2012.
When did IngagePatient last raise?
IngagePatient's most recent round was a Venture of $2.4M in Jul 2015.
What was IngagePatient's biggest round?
IngagePatient's largest round on record is $4.1M (Series A), in Oct 2012.
Who backed IngagePatient first?
IngagePatient's first round on record, in Oct 2012, was backed by Harbert Venture Partners.
What stage is IngagePatient at?
IngagePatient's latest named round is a Venture, in Jul 2015.
Where is IngagePatient based?
IngagePatient is based in the United States.
Companies like IngagePatient
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.